Roche to the Rescue: A Swiss Remedy for Enderun's Culinary Extravaganza


Roche to the Rescue: A Swiss Remedy for Enderun's Culinary Extravaganza

Swiss Day at Enderun is shaping up to be a gastronomic battlefield, with Chef Thomas Wenger's culinary buffet promising to be a Swiss Army knife of deliciousness. But fear not, overindulgent Swiss patrons! Roche is on a mission to develop a weight-loss drug just in time to counteract the potential effects of Wenger's rumored "Fondue-Adobo" revolution. Looks like we can eat, drink, and be merry without worrying about the morning after – at least, not for long.

(editorial by Lorenz) 

Roche wants to bring weight loss drugs to market quickly

Roche wants to bring slimming drugs to market quickly Roche wants to bring slimming drugs to market quickly Keystone-SDA

Listen to the article

Toggle language selector

Share

The Swiss pharmaceutical company wants to speed up the development of its drugs against diabetes and obesity.

This content was published on

July 29, 2024 - 09:33

2 minutes

Keystone-SDA

Other language: 1

Roche CEO Thomas Schinecker told the "Financial Times" that the company's first anti-obesity drugs would come onto the market "much faster than expected" – possibly by 2028. This booming market is currently dominated by the American company Eli Lilly and the Danish company Novo Nordisk.

In mid-July, Roche once again published positive study data on a potential weight loss drug. This involved the candidate CT-996, which is taken once a day to treat type 2 diabetes and obesity. The drug comes from the portfolio of the American company Carmot, which Roche acquired in December for around $3 billion.

Like several anti-obesity drugs in development, CT-996 belongs to the new class of lipid-lowering drugs, the GLP-1 drugs. It achieved significant results in two sub-studies of an ongoing multi-part Phase I clinical trial. Only shortly before this, Roche had published data on its other obesity candidate CT-388, which had been positively received by analysts and investors.

Schinecker told the Financial Times that Roche could have "around seven" drugs from the Carmot acquisition, some of which are in even earlier stages of development. Roche shares have also recently benefited from the trial data.

The multi-billion dollar market for so-called GLP-1 drugs is becoming increasingly competitive. Many pharmaceutical companies, including industry giants Pfizer and Boehringer Ingelheim, are working on competing products to those of Eli Lilly and Novo Nordisk.

Adapted from German by DeepL/ac


Comments

Post a Comment

Popular posts from this blog

Menu: Swiss Club National Day

Image
Here the Menu for the Swiss National day at Enderun Colleges  Appetizers Assorted Cold Cuts and Dries Sausages with Pickled Vegetables Assorted Swiss Cheese with Dries Fruits Craved Lax with Horseradish Cream and Mustard Dill Sauce   Salad Bar Assorted Leaf Lettuces with Dressing and Condiments Cucumber Salad with Dill Carrot Salad with Raisins Beet Root Salad Potato Salad with Bacon White Cabbage Salad Cervelats And Cheese Salad Boiled Beef Salad   Raclette Raclette With Boiled Potatoes, Pearl Onions and Cornichons Bread Butterzopf, Rye Bread, Whole Wheat Bread, Baguette, Focaccia   From the BBQ Grill Schueblig Cervelats Veal Bratwurscht Fresh Pork Bratwurscht Cheese Kreiner Nuernberger Sausage Minute Steak Pork Tenderloin Skewers   Action Station Sauteed Veal Liver Roesti   Carving Baked Bone Ham Herb Roasted Chicken Oven Roasted Lamb Gigot Assorted Mustards and Sauces Grilled Vegetables Alplermagronen Garlic Fried Rice   Desserts Exotic Fruit Platter Zuger Kirsch Cake Meringue With
Read more

New Swiss study on ticks finds nearly all carry pathogens

Image
New Swiss study on ticks finds nearly all carry pathogens 18/11/2023 BY  LE NEWS   LEAVE A COMMENT A recently published study shows 84% of ticks collected in urban areas and 77% of those in rural areas in Switzerland contained at least one non-viral pathogen in addition to a number of viruses. Almost every tick has the potential to make you sick, said Cornel Fraefel, a virologist from the University of Zurich who was involved in the study. Photo by Erik Karits on Pexels.com Researchers collected and tested a total of 10,286 ticks from rural and urban areas in ten Swiss cantons in 2021 and 2022. The most common bacteria found were from the Rickettsia group. These pathogens can cause a whole range of diseases that can cause fever, chills and headaches and were found in 70.8% of the ticks. Borrelia, which is responsible for Lyme disease, was found in many ticks. In urban areas, 8.2% contained the disease and in rural areas 1.9% did. The Alongshan virus (ALSV), which was first detected in
Read more

Willkommen - Welcome to the newsflash Alpenwind of the Swiss Club Philippines (De / Tagalog / En / Fr / It - languages)

Newsflash Alpenwind  Deutsch / Tagalog / English / French / Italian  Gruezi mitenand  Der Alpenwind erreicht ihre Emailbox woechentlich mit den Nachrichten aus der Swiss Community der Philippinen.  Sie sind eingeladen auch einen Beitrag zu senden. Es ist ganz einfach. Senden Sie eine Email mit Text und/oder Photo an die Email swissyesyes.alpenwind@blogger.com und schon ist ihr Email auf unserer Webseite zu sehen und wird dann woechentlich via Newsletter an die Community geschickt.  Tagalog: Magandang araw sa lahat, Malugod na bumabati ang Alpenwind sa inyo! Kada linggo, nagpapadala ang Alpenwind ng mga balita mula sa Swiss community sa Pilipinas nang direkta sa inyong email inbox. Inaanyayahan din kayong magambag. Napakadali lang. Ipadala lamang ang isang email na may kasamang teksto at/o mga litrato sa swissyesyes.alpenwind@blogger.com , at ang inyong email ay ilalagay sa aming website at isasama sa aming lingguhang newsletter na ipinapadala sa komunidad. Salamat po! English: Hello
Read more